Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • feng
    Member
    • Oct 2010
    • 50

    #1

    fastq quality check with Q=33 or Q=64?

    Hi all,

    I'm trying do quality checking with FASTX toolkit,


    Now I'm confused with different fastq. I list some samples as following, Is there anyone know which Q (33/64) I should used for data analysis?

    @SRR036482.94 SOLEXA8_1:2:1:0:1735 length=51
    AAAATAAAATATTGGCACAAAGAGATTTCAAAAATATCACTGCATCCTATA
    +SRR036482.94 SOLEXA8_1:2:1:0:1735 length=51
    =HCHHHEC@EHHHHHHHHDCGGBGHHHHHFHHHHHEEHHHHHFHHHHHHHD
    @SRR036482.95 SOLEXA8_1:2:1:1:1455 length=51
    ATTATAGAAAGCCAGAGGGAACTAATCACTTCAGTGCAACTGCAGCAGGTA
    +SRR036482.95 SOLEXA8_1:2:1:1:1455 length=51
    HHDDC=C7?D??DDD8ECC0ACGEGHHEDHHEHE@A8GC?:C4;D=CA@53

    Many thanks.
  • fkrueger
    Senior Member
    • Sep 2009
    • 627

    #2
    This definitely looks like Sanger quality values (Phred+33).

    See FastQ for more information on the FastQ data format.

    Comment

    • kmcarr
      Senior Member
      • May 2008
      • 1181

      #3
      fkrueger is correct, they are Sanger (Phred+33) encodings. The accession numbers (SRR) indicate that this is data downloaded from the the NCBI SRA. SRA data will always be Phred+33.

      Comment

      • aloliveira
        Member
        • Aug 2010
        • 47

        #4
        Feng,


        How are you? There is an excelent paper that describes the FASTQ encoding. But kmcarr is correct, all the FASTQ sequences from ncbi are Phred+33.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        54 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        40 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        46 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        46 views
        0 reactions
        Last Post SEQadmin2  
        Working...